NM_001370.2:c.7353A>G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001370.2(DNAH6):​c.7353A>G​(p.Thr2451Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0621 in 1,552,234 control chromosomes in the GnomAD database, including 4,495 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 1343 hom., cov: 33)
Exomes 𝑓: 0.058 ( 3152 hom. )

Consequence

DNAH6
NM_001370.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.139

Publications

7 publications found
Variant links:
Genes affected
DNAH6 (HGNC:2951): (dynein axonemal heavy chain 6) This gene belongs to the dynein family, whose members encode large proteins that are constituents of the microtubule-associated motor protein complex. This complex is composed of dynein heavy, intermediate and light chains, which can be axonemal or cytoplasmic. This protein is an axonemal dynein heavy chain. It is involved in producing force for ciliary beating by using energy from ATP hydrolysis. Mutations in this gene may cause primary ciliary dyskinesia (PCD) as well as heterotaxy. [provided by RefSeq, Jun 2016]
DNAH6 Gene-Disease associations (from GenCC):
  • male infertility with azoospermia or oligozoospermia due to single gene mutation
    Inheritance: AR Classification: MODERATE Submitted by: King Faisal Specialist Hospital and Research Center

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 2-84694309-A-G is Benign according to our data. Variant chr2-84694309-A-G is described in ClinVar as Benign. ClinVar VariationId is 402741.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.139 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.231 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH6NM_001370.2 linkc.7353A>G p.Thr2451Thr synonymous_variant Exon 46 of 77 ENST00000389394.8 NP_001361.1 Q9C0G6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH6ENST00000389394.8 linkc.7353A>G p.Thr2451Thr synonymous_variant Exon 46 of 77 5 NM_001370.2 ENSP00000374045.3 Q9C0G6-1
DNAH6ENST00000602588.1 linkn.1434A>G non_coding_transcript_exon_variant Exon 10 of 11 1

Frequencies

GnomAD3 genomes
AF:
0.102
AC:
15521
AN:
152206
Hom.:
1342
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.235
Gnomad AMI
AF:
0.0844
Gnomad AMR
AF:
0.0593
Gnomad ASJ
AF:
0.0196
Gnomad EAS
AF:
0.00211
Gnomad SAS
AF:
0.0610
Gnomad FIN
AF:
0.0409
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0556
Gnomad OTH
AF:
0.0812
GnomAD2 exomes
AF:
0.0553
AC:
8768
AN:
158578
AF XY:
0.0530
show subpopulations
Gnomad AFR exome
AF:
0.241
Gnomad AMR exome
AF:
0.0343
Gnomad ASJ exome
AF:
0.0198
Gnomad EAS exome
AF:
0.00128
Gnomad FIN exome
AF:
0.0381
Gnomad NFE exome
AF:
0.0546
Gnomad OTH exome
AF:
0.0515
GnomAD4 exome
AF:
0.0578
AC:
80911
AN:
1399910
Hom.:
3152
Cov.:
31
AF XY:
0.0573
AC XY:
39574
AN XY:
690446
show subpopulations
African (AFR)
AF:
0.239
AC:
7539
AN:
31600
American (AMR)
AF:
0.0376
AC:
1342
AN:
35708
Ashkenazi Jewish (ASJ)
AF:
0.0192
AC:
484
AN:
25182
East Asian (EAS)
AF:
0.000811
AC:
29
AN:
35738
South Asian (SAS)
AF:
0.0644
AC:
5099
AN:
79234
European-Finnish (FIN)
AF:
0.0386
AC:
1913
AN:
49512
Middle Eastern (MID)
AF:
0.0614
AC:
350
AN:
5702
European-Non Finnish (NFE)
AF:
0.0560
AC:
60447
AN:
1079064
Other (OTH)
AF:
0.0637
AC:
3708
AN:
58170
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
4316
8633
12949
17266
21582
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2396
4792
7188
9584
11980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.102
AC:
15544
AN:
152324
Hom.:
1343
Cov.:
33
AF XY:
0.0994
AC XY:
7401
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.235
AC:
9779
AN:
41552
American (AMR)
AF:
0.0592
AC:
906
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0196
AC:
68
AN:
3472
East Asian (EAS)
AF:
0.00212
AC:
11
AN:
5192
South Asian (SAS)
AF:
0.0613
AC:
296
AN:
4830
European-Finnish (FIN)
AF:
0.0409
AC:
434
AN:
10624
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0556
AC:
3783
AN:
68030
Other (OTH)
AF:
0.0803
AC:
170
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
699
1398
2097
2796
3495
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0692
Hom.:
2152
Bravo
AF:
0.107
Asia WGS
AF:
0.0460
AC:
162
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF -

DNAH6-related disorder Benign:1
Oct 28, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
3.1
DANN
Benign
0.66
PhyloP100
-0.14
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1192295; hg19: chr2-84921433; API